Central Nervous System Infections Caused by Mycobacterium abscessus: Ventricular Shunt Infection in Two Pediatric

Gabriella S Lamb1, Coralee Del Valle Mojica2, Nivedita Srinivas2

  • 1From the Department of Pediatrics, Division of Pediatric Infectious Diseases, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.

Insights

Central nervous system infections caused by Mycobacterium abscessus are rare and challenging to manage. Effective treatment requires prolonged antimycobacterial therapy and surgical removal of infected shunt material.

Area of Science:

  • Infectious Diseases
  • Pediatric Neurology
  • Neurosurgery

Background:

  • Central nervous system (CNS) infections in premature infants pose significant challenges.
  • Hydrocephalus secondary to intraventricular hemorrhage (IVH) often necessitates cerebrospinal fluid (CSF) shunting.
  • Mycobacterium abscessus is an emerging opportunistic pathogen with increasing clinical relevance.

Observation:

  • Two pediatric patients, a 4-year-old male and an 18-month-old female, both with histories of prematurity (24 and 26 weeks gestation, respectively) and IVH-induced hydrocephalus requiring shunts, presented with M. abscessus infections.
  • Infections involved both the shunt track and ventricular fluid, indicating disseminated disease.
  • The 4-year-old patient required over two months of triple intravenous antibiotics and intraventricular amikacin for CSF sterilization.

Findings:

  • Complete resolution of M. abscessus CNS infections was achieved only after complete removal of all foreign materials (shunts).
  • Extensive surgical debridement of infected shunt track tissue was crucial for infection control.
  • Prolonged combination antimycobacterial therapy was essential but associated with significant challenges.

Implications:

  • Central nervous system infections caused by Mycobacterium abscessus are rare but associated with high morbidity and mortality.
  • Management necessitates a multidisciplinary approach involving infectious disease specialists, neurosurgeons, and neurologists.
  • Aggressive surgical intervention combined with prolonged, tailored antimicrobial therapy is critical for favorable outcomes in these challenging cases.

Related Concept Videos

Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
12.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
317
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237
What is a Nervous System?01:25

What is a Nervous System?

Overview
105.1K
Stages of Infection01:26

Stages of Infection

Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
65.3K